申请人:Eli Lilly and Company
公开号:US05795886A1
公开(公告)日:1998-08-18
Compounds having general formula (I) wherein R is hydrogen or C.sub.1 -C.sub.10 alkyl; X is an aromatic moiety selected from phenyl, thienyl, furyl, pyridyl, imidazolyl, benzimidazolyl, benzothiazolyl and phthalazinyl which is unsubstituted or substituted with one or more moieties chosen from the group consisting of halogen, hydroxy, cyano, nitro, C.sub.1 -C.sub.6 alkyl, C.sub.3 -C.sub.6 cycloalkyl, C.sub.1 -C.sub.4 alkoxy, carboxy, C.sub.1 -C.sub.6 alkoxycarbonyl, acetyl, formyl, carboxymethyl, hydroxymethyl, amino, aminomethyl, methylenedioxy and trifluoromethyl; and "Aryl" represents p-nitrophenyl, p-aminophenyl or p-(protected amino) phenyl; or a pharmaceutically acceptable salt thereof, are useful as anticonvulsants.
通式(I)的化合物,其中R为氢或C.sub.1-C.sub.10烷基;X为芳香基,选择自苯基,噻吩基,呋喃基,吡啶基,咪唑基,苯并咪唑基,苯并噻唑基和邻苯二氮杂茂基,它们未被取代或被一个或多个取代基所取代,所述取代基选自卤素,羟基,氰基,硝基,C.sub.1-C.sub.6烷基,C.sub.3-C.sub.6环烷基,C.sub.1-C.sub.4烷氧基,羧基,C.sub.1-C.sub.6烷氧羰基,乙酰基,甲酰基,羧甲基,羟甲基,氨基,氨甲基,亚甲二氧基和三氟甲基;“芳基”表示对硝基苯基,对氨基苯基或对(保护氨基)苯基;或其药学上可接受的盐,用作抗癫痫药物。